SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11057441
Source:
http://linkedlifedata.com/resource/pubmed/id/11057441
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0051696
,
umls-concept:C0140591
,
umls-concept:C0311400
,
umls-concept:C0524620
,
umls-concept:C0857121
,
umls-concept:C1280500
,
umls-concept:C2826345
pubmed:issue
10
pubmed:dateCreated
2001-2-7
pubmed:abstractText
To compare the effects of rilmenidine with those of amlodipine on blood pressure, glucose metabolism, plasma lipid concentration and fibrinolysis parameters.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8306882
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amlodipine
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1
,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
,
http://linkedlifedata.com/resource/pubmed/chemical/rilmenidine
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0263-6352
pubmed:author
pubmed-author:ArgenzianoLL
,
pubmed-author:De LucaNN
,
pubmed-author:FontanaDD
,
pubmed-author:IovinoGG
,
pubmed-author:IzzoRR
,
pubmed-author:TrimarcoBB
,
pubmed-author:VecchioneCC
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1515-22
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11057441-Adult
,
pubmed-meshheading:11057441-Aged
,
pubmed-meshheading:11057441-Amlodipine
,
pubmed-meshheading:11057441-Antihypertensive Agents
,
pubmed-meshheading:11057441-Blood Glucose
,
pubmed-meshheading:11057441-Body Weight
,
pubmed-meshheading:11057441-Double-Blind Method
,
pubmed-meshheading:11057441-Female
,
pubmed-meshheading:11057441-Hemodynamics
,
pubmed-meshheading:11057441-Humans
,
pubmed-meshheading:11057441-Hypertension
,
pubmed-meshheading:11057441-Hypertriglyceridemia
,
pubmed-meshheading:11057441-Insulin
,
pubmed-meshheading:11057441-Male
,
pubmed-meshheading:11057441-Middle Aged
,
pubmed-meshheading:11057441-Oxazoles
,
pubmed-meshheading:11057441-Plasminogen Activator Inhibitor 1
,
pubmed-meshheading:11057441-Tissue Plasminogen Activator
pubmed:year
2000
pubmed:articleTitle
Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.
pubmed:affiliation
Department of Clinical Medicine and Cardiovascular Sciences, Federico II University, Naples, Italy.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't